GlassScriptPhysician profile
Tyra R Schlabach
NPI 1710395975
$931.30
in general payments reported to CMS, 2019-2025
19 companies · $16.77 in 2025
The $16.77 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $305 · 2023: $427 · 2024: $71.26 · 2025: $16.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $514.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $114.56 | 2022-2023 | |
| Incyte Corporation | $111.01 | 2022-2023 | Jakafi |
| Seagen INC. | $94.29 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $78.58 | 2022-2025 | Libtayo |
| Takeda Pharmaceuticals U.S.A., INC. | $66.60 | 2022-2023 | Ninlaro |
| Lilly USA, LLC | $63.64 | 2022-2023 | Verzenio, Retevmo, Jaypirca |
| Bayer Healthcare Pharmaceuticals INC. | $61.52 | 2022-2024 | |
| Glaxosmithkline, LLC. | $59.63 | 2023 | Zejula, Jemperli |
| Daiichi Sankyo INC. | $50.10 | 2023 | Enhertu |
| Eisai INC. | $48.98 | 2023-2024 | |
| Jazz Pharmaceuticals INC. | $39.61 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $31.92 | 2023 | Opdualag |
| Amgen INC. | $31.89 | 2023 | Lumakras |
| Gilead Sciences, INC. | $18.47 | 2023 | |
| Genzyme Corporation | $15.68 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adc Therapeutics America, INC. | $15.41 | 2023 | |
| Taiho Oncology, INC. | $13.79 | 2023 | |
| Merck Sharp & Dohme LLC | $13.78 | 2022 | |
| Genentech USA, INC. | $1.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyra Schlabach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.